Although the AI has already been actively used to accelerate research and reduce costs in the pharmaceutical industry, none of these drugs have been officially approved for mass use. Some drugs selected with the participation of AI are now the final stages of clinical studies. For example, an anchoring psoriasis tests the drug, the results are expected this year.
According to InSelico General Manager, most pharmaceutical companies use AI only at certain stages. However, Inselico himself offers machine learning technologies at every stage, from the search of goals to the optimization of molecules to move forward rapidly to clinical research.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
